Nash Clinical Trial - A Phase II Clinical Trial of Chiglitazar for NASH

Status Completed

Clinical Trial Summary

The study is to evaluate the efficacy and safety of chiglitazar monotherapy in patients with non-clcoholic steatohepatitis (NASH).

Clinical Trial Description

The study is a non-invasive exploratory phase II trial in patients who were clinically diagnosed as non-alcoholic steatohepatitis (NASH) with liver fibrosis accompanied by elevated triglycerides (TG) and insulin resistance. The efficacy and safety of chiglitazar tablets 48mg and 64mg will be compared with placebo in the 18-week-treament. ;

Study Design

Related Conditions & MeSH terms

NASH

Clinical Trial Details

NCT number	NCT05193916
Study type	Interventional
Source	Chipscreen Biosciences, Ltd.
Contact
Status	Completed
Phase	Phase 2
Start date	March 21, 2022
Completion date	January 2, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05479721` - LITMUS Imaging Study
Recruiting	`NCT06308757` - Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis	N/A
Completed	`NCT02923154` - Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)	Phase 2
Withdrawn	`NCT03980912` - Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy
Terminated	`NCT04565717` - A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)	Phase 1
Recruiting	`NCT04302051` - Assessment of Fatty Liver With Thermo-acoustic Device
Recruiting	`NCT05327127` - Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis	Phase 2
Completed	`NCT06348706` - Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 Diabetes	Phase 3
Recruiting	`NCT05935488` - Early Liver Disease Breath Detection
Active, not recruiting	`NCT06315361` - DIAbetes and NAFLD
Completed	`NCT03187496` - Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.	Phase 1
Recruiting	`NCT04442334` - The European NAFLD Registry
Recruiting	`NCT06338969` - The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis	N/A
Active, not recruiting	`NCT05669677` - Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
Not yet recruiting	`NCT04783116` - Plant Stanols and Liver Inflammation in Overweight and Obese Children	N/A
Recruiting	`NCT06193629` - A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing Atar	N/A
Completed	`NCT04006145` - A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH	Phase 2
Recruiting	`NCT04232293` - Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus	N/A
Recruiting	`NCT06410924` - A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH	Phase 2
Not yet recruiting	`NCT06427590` - Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy Subjects	Phase 1